Anterior Orientation vs Posterior Orientation in Per Oral Endoscopic Myotomy POEM for the Treatment of Achalasia

May 4, 2020 updated by: NYU Langone Health

Efficacy of Anterior Versus Posterior Myotomy Approach in Per Oral Endoscopic Myotomy (POEM) for the Treatment of Achalasia - A Single Operator Analysis

The purpose of this study is to compare the safety and efficacy of the anterior versus posterior myotomy technique in Per Oral Endoscopic Myotomy (POEM) for the treatment of Achalasia. The primary efficacy outcome is periprocedural pain requiring the use of narcotics. The secondary outcomes focus on safety which includes technical procedure duration time; tunneling time, myotomy time, and closure time; incidence of mucosotomy (transmural and non-transmural injury), capnoperitoneum, and the postoperative sequelae of gastrointestinal reflux disease (GERD). Periprocedural pain data collection will include post POEM procedure pain scores, administrations of analgesia until discharge.

The final analysis will focus on determining whether there is a statistically significant difference in the amount and severity of pain in the Anterior versus Posterior myotomy subject populations. Additional analysis will be the collection of analgesic type (narcotic versus non-narcotic), dosage, frequency, and duration of treatment from post POEM procedure in the endoscopy recovery suite until the subjects are discharged.

Study Overview

Status

Completed

Conditions

Detailed Description

Achalasia is one of the most studied esophageal motility disorders. The etiology of Achalasia is autoimmune, neurodegenerative, or viral immune. Achalasia is a consequence of the degeneration of ganglion cells in the myenteric plexus of the esophageal body and the lower esophageal sphincter (LES). The end result of the inflammatory process is the loss of inhibitory neurotransmitters nitrous oxide and vasoactive intestinal peptide causing the imbalance between excitatory and inhibitory neurons. This results in failure of the lower esophageal sphincter (LES) to relax and is associated with aperistalsis of the esophageal body, leading to difficulty swallowing, food and fluid stasis; regurgitation of undigested food, fluid and saliva; and weight loss. Achalasia is an incurable disease and treatments are only focused on the relaxation of the lower esophageal sphincter in order to allow for passage of food fluid and saliva into the stomach. It has an estimated prevalence of 10 cases per 100,000 populations and an incidence of 1-3 cases per 100,000 populations per year in the Western world.

The armamentarium of Achalasia treatment includes pharmacologic management with the use of calcium channel blockers, nitrites, phosphodiesterase inhibitor (sildenafil), anticholinergics, and beta-adrenergic agonists; endoscopy using botulinum toxin injections just above the squamocolumnar junction or pneumatic balloon dilation of the lower esophageal sphincter; open Heller Myotomy, laparoscopic Heller Myotomy, and Per Oral Endoscopic myotomy (POEM). Per oral endoscopic myotomy (POEM) is the most recent innovative treatment in the armamentarium of Achalasia treatment. Per oral endoscopic myotomy (POEM) is a natural orifice transluminal endoscopic surgery (NOTES) approach to a Heller myotomy for the treatment of Achalasia. In 2008, POEM was first performed successfully in a human subject by Haruhiro Inoue in Japan. The POEM was performed on a 36 year old patient without any documented post-operative complications. In 2009, Stavros Stavropoulos at Winthrop University Hospital (WUH) performed the first per oral endoscopic myotomy (POEM) procedure outside of Japan. The POEM was performed on a 42 year old male without documented post-operative complications. The subject had a marked improvement in objective manometric and barium esophagram findings; and improvement in subjective dysphagia score. Consequently there has been a rapidly increasing volume of POEM procedures performed in Japan, China, and throughout the United States. Stavropoulos at Winthrop University Hospital has the highest single-operator volume in the United States. The performance of POEM is still in evolution with various centers around the world performing variations on technique.

The International Per Oral Endoscopic Myotomy Survey (IPOEMS) was conducted by Stavropoulos and Savides during the July 2012 annual meeting of Natural Orifice Surgery Consortium for Assessment and Research (NOSCAR). This survey was conducted to address the scarceness of POEM literature at the time. IPOEM provided a "snapshot" of the status of POEM worldwide. The survey included 5 Asian, 7 North American, and 4 European expert centers with a combined total of 841 POEM procedures performed by July 2012. At the time most centers (14) performed right anterior myotomy (2 o'clock orientation) with only a few of centers performing posterolateral myotomy (5 o'clock orientation) determined using the usual endoscopic convention of 12 o'clock representing the most anterior aspect of the esophagus on endoluminal view.

The esophagus in humans is a complex structure with multiple muscles, nerves, vascular, and lymphatic components. Branches of the vagus nerve and visceral branches of the sympathetic trunk provide nerve fibers to the esophageal plexus. The vagus nerve delivers two fiber types to the esophageal plexus: preganglionic parasympathetic fibers and afferent fibers. These vagal fibers in the esophageal plexus reform to make the anterior vagal trunk (left vagus) and the posterior vagal trunk (right vagus). The anterior and posterior terms for the vagal trunks are used in relation to the esophagus. The visceral branches of the sympathetic trunk delivers two fiber types to the esophageal plexus: sympathetic postganglionic fibers and the afferent fibers. The afferent fibers originating from the sympathetic trunk are primarily involved with pain. The critical anatomical component of the esophagus in the treatment of Achalasia is the lower esophageal sphincter. Per common convention, the most anterior point of the LES point is assigned as the 12 o'clock position. The strong oblique sling fiber component is centered at 7o'clock on the posterolateral wall and wraps over the anterior and posterior walls at 11 o'clock and 5 o'clock, respectively. The weaker circular clasp fiber component location is centered at 2 o'clock to 3 o'clock. The question of investigating the optimal orientation to perform the myotomy is unique to POEM. Open Heller myotomy and laparoscopic Heller myotomy are limited to the anterior aspect of the esophagus. Myotomy orientation is constrained by the anatomical locations of the left bronchus, left atrium and spine. Anterior orientation is forced between the 1 o'clock - 2 o'clock position secondary to the locations of the left bronchus and left atrium between 10 o'clock -11 o'clock and 12 o'clock - 1 o'clock, respectively. Posterior orientation is forced between the 4 o'clock - 5 o'clock positions secondary to the location of the spine located between 8 o'clock-9 o'clock positions .The sling fibers maintain the angle of His and are a significant antireflux barrier. Stavropoulos et al, reported on a single operator series of 284 POEM subjects at Digestive Disease Week in May 2016. A statistical difference was found in the number of subjects requiring narcotics post POEM procedure Subjects who had an anterior myotomy were less likely to require narcotics post POEM procedure than those subjects who had a posterior myotomy, 35% versus 53% respectively (p=0.007).

To date, there have been no prospective randomized controlled studies conducted comparing anterior versus posterior myotomy technique in POEM analyzing perioperative pain, procedure duration, incidence of mucosotomy, capnoperitoneum, and the postoperative sequelae of gastrointestinal reflux disease (GERD).

Study Type

Interventional

Enrollment (Actual)

89

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New York
      • Mineola, New York, United States, 11501
        • NYU Winthrop Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Subjects who have been diagnosed with Achalasia Type I, II, or III by positive manometric findings and supporting findings by timed barium esophagram and endoscopy.
  2. Subjects who are willing and competent to sign Informed Consent and to comply with study related visits and procedures.

Exclusion Criteria:

  1. Subjects who are under 18 years of age
  2. Subjects with Achalasia Type I, II, or III who have had a prior failed open or laparoscopic Heller myotomy; or have an esophageal diverticula, or anatomical variant dictating the approach of the myotomy
  3. Subjects diagnosed with other motility disorders such as distal esophageal spasm (DES), hypertensive peristalsis (Nutcracker), or hypercontractile esophagus (Jackhammer)
  4. Subjects with coagulopathy
  5. Pregnant females
  6. Subjects who in the investigators' opinion, are medically unstable , are unable to give informed consent, or whose risks outweigh the benefits of participating in the study
  7. Subjects with decisional incapacity who are unable to comply with study related visits and procedures

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Anterior Orientation

The anterior endoscopic myotomy of the lower esophageal sphincter will be performed between the 11 o'clock to 3 o'clock position in the esophagus determined by the usual endoscopic convention of 12 o'clock representing the most anterior aspect of the esophagus on endoluminal view.

Intervention is the endoscopic myotomy of the lower esophageal sphincter.

The Per Oral Endoscopic Myotomy procedure is the cutting of the lower esophageal sphincter. This procedure is a natural orifice transluminal endoscopic surgery (NOTES)
Active Comparator: Posterior Orientation

The posterior endoscopic myotomy of the lower esophageal sphincter will be performed between the 5 o'clock to 6 o'clock position in the esophagus determined by the usual endoscopic convention of 12 o'clock representing the most anterior aspect of the esophagus on endoluminal view.

Intervention is the endoscopic myotomy of the lower esophageal sphincter.

The Per Oral Endoscopic Myotomy procedure is the cutting of the lower esophageal sphincter. This procedure is a natural orifice transluminal endoscopic surgery (NOTES)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Periprocedural pain requiring the use of narcotics.
Time Frame: Within the first 48 hours after the procedure.
Pain related to the endoscopic myotomy requiring the use of narcotic pain medication.
Within the first 48 hours after the procedure.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of Gastrointestinal Reflux Disease (GERD)
Time Frame: Within 3 months after the procedure.
Gastrointestinal Reflux Disease measured by BRAVO pH study
Within 3 months after the procedure.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Stavros Stavropoulos, MD, NYU Langone Winthrop

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 24, 2017

Primary Completion (Actual)

May 18, 2018

Study Completion (Actual)

May 24, 2019

Study Registration Dates

First Submitted

July 13, 2017

First Submitted That Met QC Criteria

July 21, 2017

First Posted (Actual)

July 25, 2017

Study Record Updates

Last Update Posted (Actual)

May 5, 2020

Last Update Submitted That Met QC Criteria

May 4, 2020

Last Verified

May 1, 2020

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • WUH 17008
  • 18-01666 (Other Identifier: NYULangone Institutional Review Board)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Achalasia

Clinical Trials on Per Oral Endoscopic Myotomy

Subscribe